Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study-Reference-Cited by-同舟云学术

Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study

Published:2020-06-03 Issue:6 Volume:15 Page:e0233595
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mitchell Paul^ORCID,Sheidow Tom G.,Farah Michel E.^ORCID,Mahmood Sajjad,Minnella Angelo M.,Eter Nicole,Eldem Bora,Al-Dhibi Hassan^ORCID,Macfadden Wayne,Parikh Soumil,Dunger-Baldauf Cornelia,Mahgoub Mohamed M.,Schmidt-Erfurth Ursula,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Diabetic macular oedema: a clinical overview;A Girach;International journal of clinical practice,2007

2. Overview of diabetic macular edema;NM Holekamp;The American journal of managed care,2016

3. IDF Diabetes Atlas, Seventh Edition. International Diabetes Federation website. http://www.oedg.at/pdf/1606_IDF_Atlas_2015_UK.pdf (accessed 24 Nov, 2017).

4. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections;H King;Diabetes care,1998

5. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;S Wild;Diabetes care,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study;European Journal of Ophthalmology;2024-08-14

2. Uveitis in the Pediatric Population and Therapeutic Management: A Current Literature Review;Children;2024-06-25

3. Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice;Ophthalmology Science;2024-05

4. KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema;American Journal of Ophthalmology;2024-04

5. Real-World Experience with Brolucizumab Compared to Aflibercept in Treatment-Naïve and Therapy-Refractory Patients with Diabetic Macular Edema;Journal of Clinical Medicine;2024-03-21